FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Biology (Basel) / Biological Potential of Polyphenols in the Context of Metabo...
Biology2022; 11(4); 559; doi: 10.3390/biology11040559

Biological Potential of Polyphenols in the Context of Metabolic Syndrome: An Analysis of Studies on Animal Models.

Abstract: Metabolic syndrome (MetS) is a disease that has a complex etiology. It is defined as the co-occurrence of several pathophysiological disorders, including obesity, hyperglycemia, hypertension, and dyslipidemia. MetS is currently a severe problem in the public health care system. As its prevalence increases every year, it is now considered a global problem among adults and young populations. The treatment of choice comprises lifestyle changes based mainly on diet and physical activity. Therefore, researchers have been attempting to discover new substances that could help reduce or even reverse the symptoms when added to food. These attempts have resulted in numerous studies. Many of them have investigated the bioactive potential of polyphenols as a "possible remedy", stemming from their antioxidative and anti-inflammatory effects and properties normalizing carbohydrate and lipid metabolism. Polyphenols may be supportive in preventing or delaying the onset of MetS or its complications. Additionally, the consumption of food rich in polyphenols should be considered as a supplement for antidiabetic drugs. To ensure the relevance of the studies on polyphenols' properties, mechanisms of action, and potential human health benefits, researchers have used laboratory animals displaying pathophysiological changes specific to MetS. Polyphenols or their plant extracts were chosen according to the most advantageous mitigation of pathological changes in animal models best reflecting the components of MetS. The present paper comprises an overview of animal models of MetS, and promising polyphenolic compounds whose bioactive potential, effect on metabolic pathways, and supplementation-related benefits were analyzed based on in vivo animal models.
Get Full Text
Publication Date: 2022-04-07 PubMed ID: 35453758PubMed Central: PMC9029039DOI: 10.3390/biology11040559Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper evaluates the potential benefits of polyphenols, plant chemicals with anti-inflammatory and antioxidant properties, in managing metabolic syndrome (MetS), a condition characterized by a group of disorders including obesity, high blood pressure, abnormal cholesterol levels, and high blood sugar. Various animal models of MetS were utilized to determine the effects of different polyphenolic compounds.

Understanding Metabolic Syndrome and Polyphenols

  • Metabolic Syndrome, also known as MetS, is a health concern that includes a set of various disorders such as obesity, high blood sugar, irregular cholesterol levels, and high blood pressure. It is a global issue, affecting both adults and young individuals.
  • Polyphenols are compounds found in plants known for their anti-inflammatory and antioxidative effects. They may potentially aid in regulating carbohydrate and lipid metabolism, which are crucial aspects of MetS.

Role of Diet and Physical Activity in MetS Management

  • Management of MetS primarily involves lifestyle modifications, notably changes in diet and physical activity. Researchers are studying the addition of specific substances to food that could assist in mitigating or even reversing symptoms of MetS.
  • Polyphenols are among these substances, with many studies investigating their bioactive potential as possible remedies for MetS due to their health benefits.

Beneficial Effects of Polyphenols on MetS

  • Studies suggest that polyphenols could be beneficial in preventing or delaying the onset of MetS and its accompanying complications.
  • Consuming food rich in polyphenols could potentially supplement antidiabetic medications, further aiding in the management of MetS.

Experimental Studies on Polyphenols and MetS using Animal Models

  • To ensure the validity of the studies on polyphenols’ properties, mechanisms of action, and health benefits, researchers have used laboratory animals that exhibit MetS-specific pathophysiological changes.
  • Various polyphenolic compounds and plant extracts were selected, focusing on those that most effectively mitigated the pathological changes in MetS-representing animal models.
  • The paper provides a comprehensive overview of the animal models used for MetS, and the polyphenolic compounds that displayed promising results in influencing metabolic pathways, and benefits related to supplementation.

Cite This Article

APA
Niewiadomska J, Gajek-Marecka A, Gajek J, Noszczyk-Nowak A. (2022). Biological Potential of Polyphenols in the Context of Metabolic Syndrome: An Analysis of Studies on Animal Models. Biology (Basel), 11(4), 559. https://doi.org/10.3390/biology11040559

Publication

Biology
ISSN: 2079-7737
NlmUniqueID: 101587988
Country: Switzerland
Language: English
Volume: 11
Issue: 4
PII: 559

Researcher Affiliations

Niewiadomska, Joanna
  • Doctoral School of Wroclaw, University of Environmental and Life Sciences, 50-375 Wroclaw, Poland.
Gajek-Marecka, Aleksandra
  • Department of Cardiology, Kłodzko County Hospital, 57-300 Kłodzko, Poland.
Gajek, Jacek
  • Department of Emergency Medical Service, Wroclaw Medical University, 50-556 Wroclaw, Poland.
Noszczyk-Nowak, Agnieszka
  • Department of Internal and Diseases with Clinic for Horses, Dogs, and Cats, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland.

Grant Funding

  • PPI/APM/2019/1/00044/U/00001 / Polish National Agency for Academic Exchange

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 110 references
  1. Saklayen MG. The Global Epidemic of the Metabolic Syndrome.. Curr Hypertens Rep 2018 Feb 26;20(2):12.
    doi: 10.1007/s11906-018-0812-zpmc: PMC5866840pubmed: 29480368google scholar: lookup
  2. McCracken E, Monaghan M, Sreenivasan S. Pathophysiology of the metabolic syndrome.. Clin Dermatol 2018 Jan-Feb;36(1):14-20.
    doi: 10.1016/j.clindermatol.2017.09.004pubmed: 29241747google scholar: lookup
  3. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.. Circulation 2009 Oct 20;120(16):1640-5.
    pubmed: 19805654doi: 10.1161/circulationaha.109.192644google scholar: lookup
  4. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.. Diabet Med 1998 Jul;15(7):539-53.
    doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-Spubmed: 9686693google scholar: lookup
  5. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.. Diabet Med 2006 May;23(5):469-80.
    doi: 10.1111/j.1464-5491.2006.01858.xpubmed: 16681555google scholar: lookup
  6. Wen J, Yang J, Shi Y, Liang Y, Wang F, Duan X, Lu X, Tao Q, Lu X, Tian Y, Wang N. Comparisons of different metabolic syndrome definitions and associations with coronary heart disease, stroke, and peripheral arterial disease in a rural Chinese population.. PLoS One 2015;10(5):e0126832.
    doi: 10.1371/journal.pone.0126832pmc: PMC4427409pubmed: 25961739google scholar: lookup
  7. Wang HH, Lee DK, Liu M, Portincasa P, Wang DQ. Novel Insights into the Pathogenesis and Management of the Metabolic Syndrome.. Pediatr Gastroenterol Hepatol Nutr 2020 May;23(3):189-230.
    doi: 10.5223/pghn.2020.23.3.189pmc: PMC7231748pubmed: 32483543google scholar: lookup
  8. Dabke K, Hendrick G, Devkota S. The gut microbiome and metabolic syndrome.. J Clin Invest 2019 Oct 1;129(10):4050-4057.
    doi: 10.1172/JCI129194pmc: PMC6763239pubmed: 31573550google scholar: lookup
  9. Penman K. Does Metabolic Syndrome Increase Cardiovascular Risk?. Ph.D. Thesis. Auckland University of Technology; Auckland, New Zealand: 2011.
  10. Tune JD, Goodwill AG, Sassoon DJ, Mather KJ. Cardiovascular consequences of metabolic syndrome.. Transl Res 2017 May;183:57-70.
    doi: 10.1016/j.trsl.2017.01.001pmc: PMC5393930pubmed: 28130064google scholar: lookup
  11. Cao HL, Chen XB, Lu JG, Hou ZH, Tang X, Gao Y, Yu FF, Jiang SL, Zhao LC, Li Y, Budoff MJ, Detrano R, Lu B. Metabolic syndrome and coronary artery calcification: a community-based natural population study.. Chin Med J (Engl) 2013;126(24):4618-23.
    pubmed: 24342299
  12. Marjani A. Metabolic syndrome and diabetes: A review. J. Clin. Basic Res. 2017;1:36–43.
  13. Zhang P, Tian B. Metabolic syndrome: an important risk factor for Parkinson's disease.. Oxid Med Cell Longev 2014;2014:729194.
    doi: 10.1155/2014/729194pmc: PMC4052080pubmed: 24955210google scholar: lookup
  14. Kostoglou-Athanassiou I, Athanassiou P. Metabolic syndrome and sleep apnea.. Hippokratia 2008 Apr;12(2):81-6.
    pmc: PMC2464309pubmed: 18923660
  15. Russo A, Autelitano M, Bisanti L. Metabolic syndrome and cancer risk.. Eur J Cancer 2008 Jan;44(2):293-7.
    doi: 10.1016/j.ejca.2007.11.005pubmed: 18055193google scholar: lookup
  16. Braun S, Bitton-Worms K, LeRoith D. The link between the metabolic syndrome and cancer.. Int J Biol Sci 2011;7(7):1003-15.
    doi: 10.7150/ijbs.7.1003pmc: PMC3164150pubmed: 21912508google scholar: lookup
  17. Metere A, Giacomelli L. Absorption, metabolism and protective role of fruits and vegetables polyphenols against gastric cancer.. Eur Rev Med Pharmacol Sci 2017 Dec;21(24):5850-5858.
    doi: 10.26355/eurrev_201712_14034pubmed: 29272023google scholar: lookup
  18. Bastien M, Poirier P, Lemieux I, Després JP. Overview of epidemiology and contribution of obesity to cardiovascular disease.. Prog Cardiovasc Dis 2014 Jan-Feb;56(4):369-81.
    doi: 10.1016/j.pcad.2013.10.016pubmed: 24438728google scholar: lookup
  19. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome.. Nature 2006 Dec 14;444(7121):881-7.
    doi: 10.1038/nature05488pubmed: 17167477google scholar: lookup
  20. Buse J.B., Polonsky K.S., Burant C.F.. Type 2 diabetes mellitus. Williams Textbook of Endocrinology. Elsevier/Saunders; Philadelphia, PA, USA: 2011; pp. 1371–1435.
  21. Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant states.. Cold Spring Harb Perspect Biol 2014 Jan 1;6(1).
    doi: 10.1101/cshperspect.a009191pmc: PMC3941218pubmed: 24384568google scholar: lookup
  22. Yu JS, Cui W. Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination.. Development 2016 Sep 1;143(17):3050-60.
    doi: 10.1242/dev.137075pubmed: 27578176google scholar: lookup
  23. Schulman IH, Zhou MS. Vascular insulin resistance: a potential link between cardiovascular and metabolic diseases.. Curr Hypertens Rep 2009 Feb;11(1):48-55.
    doi: 10.1007/s11906-009-0010-0pubmed: 19146801google scholar: lookup
  24. Zhou MS, Wang A, Yu H. Link between insulin resistance and hypertension: What is the evidence from evolutionary biology?. Diabetol Metab Syndr 2014 Jan 31;6(1):12.
    doi: 10.1186/1758-5996-6-12pmc: PMC3996172pubmed: 24485020google scholar: lookup
  25. Zafar U, Khaliq S, Ahmad HU, Manzoor S, Lone KP. Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links.. Hormones (Athens) 2018 Sep;17(3):299-313.
    doi: 10.1007/s42000-018-0051-3pubmed: 30171523google scholar: lookup
  26. Wilcox G. Insulin and insulin resistance.. Clin Biochem Rev 2005 May;26(2):19-39.
    pmc: PMC1204764pubmed: 16278749
  27. Cignarelli A, Genchi VA, Perrini S, Natalicchio A, Laviola L, Giorgino F. Insulin and Insulin Receptors in Adipose Tissue Development.. Int J Mol Sci 2019 Feb 11;20(3).
    doi: 10.3390/ijms20030759pmc: PMC6387287pubmed: 30754657google scholar: lookup
  28. Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds.. Ther Adv Cardiovasc Dis 2017 Aug;11(8):215-225.
    doi: 10.1177/1753944717711379pmc: PMC5933580pubmed: 28639538google scholar: lookup
  29. Alkadi H. A Review on Free Radicals and Antioxidants.. Infect Disord Drug Targets 2020;20(1):16-26.
    doi: 10.22192/ijcrms.2018.04.02.019pubmed: 29952268google scholar: lookup
  30. Smith MM, Minson CT. Obesity and adipokines: effects on sympathetic overactivity.. J Physiol 2012 Apr 15;590(8):1787-801.
    doi: 10.1113/jphysiol.2011.221036pmc: PMC3573303pubmed: 22351630google scholar: lookup
  31. Bovolini A, Garcia J, Andrade MA, Duarte JA. Metabolic Syndrome Pathophysiology and Predisposing Factors.. Int J Sports Med 2021 Mar;42(3):199-214.
    doi: 10.1055/a-1263-0898pubmed: 33075830google scholar: lookup
  32. Campese VM, Ye S, Zhong H, Yanamadala V, Ye Z, Chiu J. Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity.. Am J Physiol Heart Circ Physiol 2004 Aug;287(2):H695-703.
    doi: 10.1152/ajpheart.00619.2003pubmed: 15277201google scholar: lookup
  33. Han Y, Zhang Y, Wang HJ, Gao XY, Wang W, Zhu GQ. Reactive oxygen species in paraventricular nucleus modulates cardiac sympathetic afferent reflex in rats.. Brain Res 2005 Oct 5;1058(1-2):82-90.
    doi: 10.1016/j.brainres.2005.07.055pubmed: 16153615google scholar: lookup
  34. Whaley-Connell A, Pavey BS, Chaudhary K, Saab G, Sowers JR. Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection.. Ther Adv Cardiovasc Dis 2007 Oct;1(1):27-35.
    doi: 10.1177/1753944707082697pubmed: 19124393google scholar: lookup
  35. Collins S. A heart-adipose tissue connection in the regulation of energy metabolism.. Nat Rev Endocrinol 2014 Mar;10(3):157-63.
    doi: 10.1038/nrendo.2013.234pubmed: 24296515google scholar: lookup
  36. Stapleton PA, James ME, Goodwill AG, Frisbee JC. Obesity and vascular dysfunction.. Pathophysiology 2008 Aug;15(2):79-89.
    doi: 10.1016/j.pathophys.2008.04.007pmc: PMC2593649pubmed: 18571908google scholar: lookup
  37. Ciccarelli M, Santulli G, Pascale V, Trimarco B, Iaccarino G. Adrenergic receptors and metabolism: role in development of cardiovascular disease.. Front Physiol 2013 Oct 3;4:265.
    doi: 10.3389/fphys.2013.00265pmc: PMC3789271pubmed: 24106479google scholar: lookup
  38. Grassi G, Dell'Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives.. J Hypertens 2004 Dec;22(12):2363-9.
    doi: 10.1097/00004872-200412000-00019pubmed: 15614031google scholar: lookup
  39. Cabandugama PK, Gardner MJ, Sowers JR. The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardiorenal Metabolic Syndrome.. Med Clin North Am 2017 Jan;101(1):129-137.
    doi: 10.1016/j.mcna.2016.08.009pmc: PMC5125542pubmed: 27884224google scholar: lookup
  40. Turkbey EB, McClelland RL, Kronmal RA, Burke GL, Bild DE, Tracy RP, Arai AE, Lima JA, Bluemke DA. The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA).. JACC Cardiovasc Imaging 2010 Mar;3(3):266-74.
    doi: 10.1016/j.jcmg.2009.10.012pmc: PMC3037096pubmed: 20223423google scholar: lookup
  41. Cuspidi C, Rescaldani M, Sala C, Grassi G. Left-ventricular hypertrophy and obesity: a systematic review and meta-analysis of echocardiographic studies.. J Hypertens 2014 Jan;32(1):16-25.
    doi: 10.1097/HJH.0b013e328364fb58pubmed: 24309485google scholar: lookup
  42. Berwick ZC, Dick GM, Tune JD. Heart of the matter: coronary dysfunction in metabolic syndrome.. J Mol Cell Cardiol 2012 Apr;52(4):848-56.
    doi: 10.1016/j.yjmcc.2011.06.025pmc: PMC3206994pubmed: 21767548google scholar: lookup
  43. Wong ND, Nelson JC, Granston T, Bertoni AG, Blumenthal RS, Carr JJ, Guerci A, Jacobs DR Jr, Kronmal R, Liu K, Saad M, Selvin E, Tracy R, Detrano R. Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: the Multiethnic Study of Atherosclerosis study.. JACC Cardiovasc Imaging 2012 Apr;5(4):358-66.
    doi: 10.1016/j.jcmg.2011.12.015pmc: PMC3327555pubmed: 22498324google scholar: lookup
  44. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atheroslcerosis.. Am J Physiol Heart Circ Physiol 2005 May;288(5):H2031-41.
    doi: 10.1152/ajpheart.01058.2004pubmed: 15653761google scholar: lookup
  45. Cory H, Passarelli S, Szeto J, Tamez M, Mattei J. The Role of Polyphenols in Human Health and Food Systems: A Mini-Review.. Front Nutr 2018;5:87.
    doi: 10.3389/fnut.2018.00087pmc: PMC6160559pubmed: 30298133google scholar: lookup
  46. Abbas M., Saeed F., Anjum F.M., Afzaal M., Tufail T., Bashir M.S., Ishtiaq A., Hussain S., Suleria H.A.R.. Natural polyphenols: An overview. Int. J. Food Prop. 2017;20:1689–1699.
    doi: 10.1080/10942912.2016.1220393google scholar: lookup
  47. Rasouli H., Farzaei M.H., Khodarahmi R.. Polyphenols and their benefits: A review. Int. J. Food Prop. 2017;20:1700–1741.
    doi: 10.1080/10942912.2017.1354017google scholar: lookup
  48. Belščak-Cvitanović A., Durgo K., Huđek A., Bačun-Družina V., Komes D.. 1—Overview of polyphenols and their properties. In: Galanakis C.M., editor. Polyphenols: Properties, Recovery, and Applications. Woodhead Publishing; Vienna, Austria: 2018; pp. 3–44.
    doi: 10.1016/B978-0-12-813572-3.00001-4google scholar: lookup
  49. Wong SK, Chin KY, Suhaimi FH, Fairus A, Ima-Nirwana S. Animal models of metabolic syndrome: a review.. Nutr Metab (Lond) 2016;13:65.
    doi: 10.1186/s12986-016-0123-9pmc: PMC5050917pubmed: 27708685google scholar: lookup
  50. Kleinert M, Clemmensen C, Hofmann SM, Moore MC, Renner S, Woods SC, Huypens P, Beckers J, de Angelis MH, Schürmann A, Bakhti M, Klingenspor M, Heiman M, Cherrington AD, Ristow M, Lickert H, Wolf E, Havel PJ, Müller TD, Tschöp MH. Animal models of obesity and diabetes mellitus.. Nat Rev Endocrinol 2018 Mar;14(3):140-162.
    doi: 10.1038/nrendo.2017.161pubmed: 29348476google scholar: lookup
  51. Conn P.M. Animal Models for the Study of Human Disease. Academic Press; Lubbock, TX, USA: 2017.
  52. Suckow M.A., Hankenson F.C., Wilson R.P., Foley P.L. The Laboratory Rat. Academic Press; Lexington, KY, USA: 2019.
  53. Almatroodi S.A., Almatroudi A., Alsahli M.A., Rahman A.H.. Grapes and their Bioactive Compounds: Role in Health Management Through Modulating Various Biological Activities. Pharmacogn. J. 2020;12:1455–1462.
    doi: 10.5530/pj.2020.12.200google scholar: lookup
  54. Xia EQ, Deng GF, Guo YJ, Li HB. Biological activities of polyphenols from grapes.. Int J Mol Sci 2010 Feb 4;11(2):622-46.
    doi: 10.3390/ijms11020622pmc: PMC2852857pubmed: 20386657google scholar: lookup
  55. Ferrières J. The French paradox: lessons for other countries.. Heart 2004 Jan;90(1):107-11.
    doi: 10.1136/heart.90.1.107pmc: PMC1768013pubmed: 14676260google scholar: lookup
  56. Obrenovich M, Siddiqui B, McCloskey B, Reddy VP. The Microbiota-Gut-Brain Axis Heart Shunt Part I: The French Paradox, Heart Disease and the Microbiota.. Microorganisms 2020 Mar 30;8(4).
    doi: 10.3390/microorganisms8040490pmc: PMC7232195pubmed: 32235574google scholar: lookup
  57. Ritz MF, Curin Y, Mendelowitsch A, Andriantsitohaina R. Acute treatment with red wine polyphenols protects from ischemia-induced excitotoxicity, energy failure and oxidative stress in rats.. Brain Res 2008 Nov 6;1239:226-34.
    doi: 10.1016/j.brainres.2008.08.073pubmed: 18801346google scholar: lookup
  58. Álvarez E, Rodiño-Janeiro BK, Jerez M, Ucieda-Somoza R, Núñez MJ, González-Juanatey JR. Procyanidins from grape pomace are suitable inhibitors of human endothelial NADPH oxidase.. J Cell Biochem 2012 Apr;113(4):1386-96.
    doi: 10.1002/jcb.24011pubmed: 22134950google scholar: lookup
  59. Chen ML, Yi L, Jin X, Liang XY, Zhou Y, Zhang T, Xie Q, Zhou X, Chang H, Fu YJ, Zhu JD, Zhang QY, Mi MT. Resveratrol attenuates vascular endothelial inflammation by inducing autophagy through the cAMP signaling pathway.. Autophagy 2013 Dec;9(12):2033-45.
    doi: 10.4161/auto.26336pubmed: 24145604google scholar: lookup
  60. Agouni A, Lagrue-Lak-Hal AH, Mostefai HA, Tesse A, Mulder P, Rouet P, Desmoulin F, Heymes C, Martínez MC, Andriantsitohaina R. Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa).. PLoS One 2009;4(5):e5557.
    doi: 10.1371/journal.pone.0005557pmc: PMC2679212pubmed: 19440378google scholar: lookup
  61. Agouni A, Mostefai HA, Lagrue AH, Sladkova M, Rouet P, Desmoulin F, Pechanova O, Martínez MC, Andriantsitohaina R. Paradoxical Effect of Nonalcoholic Red Wine Polyphenol Extract, Provinols™, in the Regulation of Cyclooxygenases in Vessels from Zucker Fatty Rats (fa/fa).. Oxid Med Cell Longev 2017;2017:8536910.
    doi: 10.1155/2017/8536910pmc: PMC5474272pubmed: 28660008google scholar: lookup
  62. Sehaber-Sierakowski CC, Vieira-Frez FC, Hermes-Uliana C, Martins HA, Bossolani GDP, Lima MM, Blegniski FP, Guarnier FA, Baracat MM, Perles JVCM, Zanoni JN. Protective effects of quercetin-loaded microcapsules on the enteric nervous system of diabetic rats.. Auton Neurosci 2021 Jan;230:102759.
    doi: 10.1016/j.autneu.2020.102759pubmed: 33341532google scholar: lookup
  63. Tan Y, Kim J, Cheng J, Ong M, Lao WG, Jin XL, Lin YG, Xiao L, Zhu XQ, Qu XQ. Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats.. World J Gastroenterol 2017 Jun 7;23(21):3805-3814.
    doi: 10.3748/wjg.v23.i21.3805pmc: PMC5467066pubmed: 28638220google scholar: lookup
  64. Kao YH, Hiipakka RA, Liao S. Modulation of endocrine systems and food intake by green tea epigallocatechin gallate.. Endocrinology 2000 Mar;141(3):980-7.
    doi: 10.1210/endo.141.3.7368pubmed: 10698173google scholar: lookup
  65. Cheng J, Tan Y, Zhou J, Xiao L, Johnson M, Qu X. Green tea polyphenols ameliorate metabolic abnormalities and insulin resistance by enhancing insulin signalling in skeletal muscle of Zucker fatty rats.. Clin Sci (Lond) 2020 May 29;134(10):1167-1180.
    doi: 10.1042/CS20200107pubmed: 32458968google scholar: lookup
  66. Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical.. Eur J Pharmacol 2008 May 13;585(2-3):325-37.
    doi: 10.1016/j.ejphar.2008.03.008pubmed: 18417116google scholar: lookup
  67. Anand David AV, Arulmoli R, Parasuraman S. Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid.. Pharmacogn Rev 2016 Jul-Dec;10(20):84-89.
    doi: 10.4103/0973-7847.194044pmc: PMC5214562pubmed: 28082789google scholar: lookup
  68. Li LJ, Li GW, Xie Y. [Regulatory effects of glabridin and quercetin on energy metabolism of breast cancer cells].. Zhongguo Zhong Yao Za Zhi 2019 Sep;44(17):3786-3791.
    doi: 10.19540/j.cnki.cjcmm.20190505.401pubmed: 31602954google scholar: lookup
  69. Kim GT, Lee SH, Kim JI, Kim YM. Quercetin regulates the sestrin 2-AMPK-p38 MAPK signaling pathway and induces apoptosis by increasing the generation of intracellular ROS in a p53-independent manner.. Int J Mol Med 2014 Apr;33(4):863-9.
    doi: 10.3892/ijmm.2014.1658pmc: PMC3976123pubmed: 24535669google scholar: lookup
  70. Chang JH, Lai SL, Chen WS, Hung WY, Chow JM, Hsiao M, Lee WJ, Chien MH. Quercetin suppresses the metastatic ability of lung cancer through inhibiting Snail-dependent Akt activation and Snail-independent ADAM9 expression pathways.. Biochim Biophys Acta Mol Cell Res 2017 Oct;1864(10):1746-1758.
    doi: 10.1016/j.bbamcr.2017.06.017pubmed: 28648644google scholar: lookup
  71. Salvamani S, Gunasekaran B, Shaharuddin NA, Ahmad SA, Shukor MY. Antiartherosclerotic effects of plant flavonoids.. Biomed Res Int 2014;2014:480258.
    doi: 10.1155/2014/480258pmc: PMC4058282pubmed: 24971331google scholar: lookup
  72. Wang YY, Chang CY, Lin SY, Wang JD, Wu CC, Chen WY, Kuan YH, Liao SL, Wang WY, Chen CJ. Quercetin protects against cerebral ischemia/reperfusion and oxygen glucose deprivation/reoxygenation neurotoxicity.. J Nutr Biochem 2020 Sep;83:108436.
    doi: 10.1016/j.jnutbio.2020.108436pubmed: 32599520google scholar: lookup
  73. Wang W., Sun C., Mao L., Ma P., Liu F., Yang J., Gao Y.. The biological activities, chemical stability, metabolism and delivery systems of quercetin: A review. Trends Food Sci. Technol. 2016;56:21–38.
    doi: 10.1016/j.tifs.2016.07.004google scholar: lookup
  74. Rivera L, Morón R, Sánchez M, Zarzuelo A, Galisteo M. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats.. Obesity (Silver Spring) 2008 Sep;16(9):2081-7.
    doi: 10.1038/oby.2008.315pubmed: 18551111google scholar: lookup
  75. Melmed S., Polonsky K.S., Larsen P.R., Kronenberg H.M. Williams Textbook of Endocrinology E-Book. Elsevier Health Sciences; Philadelphia, PA, USA: 2015.
  76. Kowluru RA, Mishra M, Kowluru A, Kumar B. Hyperlipidemia and the development of diabetic retinopathy: Comparison between type 1 and type 2 animal models.. Metabolism 2016 Oct;65(10):1570-81.
    doi: 10.1016/j.metabol.2016.07.012pmc: PMC5023070pubmed: 27621192google scholar: lookup
  77. Szabó K, Énzsöly A, Dékány B, Szabó A, Hajdú RI, Radovits T, Mátyás C, Oláh A, Laurik LK, Somfai GM, Merkely B, Szél Á, Lukáts Á. Histological Evaluation of Diabetic Neurodegeneration in the Retina of Zucker Diabetic Fatty (ZDF) Rats.. Sci Rep 2017 Aug 21;7(1):8891.
    doi: 10.1038/s41598-017-09068-6pmc: PMC5566374pubmed: 28827737google scholar: lookup
  78. Zarfeshany A, Asgary S, Javanmard SH. Potent health effects of pomegranate.. Adv Biomed Res 2014;3:100.
    doi: 10.4103/2277-9175.129371pmc: PMC4007340pubmed: 24800189google scholar: lookup
  79. Johanningsmeier SD, Harris GK. Pomegranate as a functional food and nutraceutical source.. Annu Rev Food Sci Technol 2011;2:181-201.
    doi: 10.1146/annurev-food-030810-153709pubmed: 22129380google scholar: lookup
  80. Xu KZ, Zhu C, Kim MS, Yamahara J, Li Y. Pomegranate flower ameliorates fatty liver in an animal model of type 2 diabetes and obesity.. J Ethnopharmacol 2009 Jun 22;123(2):280-7.
    doi: 10.1016/j.jep.2009.03.035pubmed: 19429373google scholar: lookup
  81. Huang TH, Yang Q, Harada M, Li GQ, Yamahara J, Roufogalis BD, Li Y. Pomegranate flower extract diminishes cardiac fibrosis in Zucker diabetic fatty rats: modulation of cardiac endothelin-1 and nuclear factor-kappaB pathways.. J Cardiovasc Pharmacol 2005 Dec;46(6):856-62.
    doi: 10.1097/01.fjc.0000190489.85058.7epubmed: 16306813google scholar: lookup
  82. Huang TH, Peng G, Kota BP, Li GQ, Yamahara J, Roufogalis BD, Li Y. Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids.. Br J Pharmacol 2005 Jul;145(6):767-74.
    doi: 10.1038/sj.bjp.0706245pmc: PMC1576197pubmed: 15880139google scholar: lookup
  83. Campia U, Panza JA. Flavanol-rich cocoa a promising new dietary intervention to reduce cardiovascular risk in type 2 diabetes?. J Am Coll Cardiol 2008 Jun 3;51(22):2150-2.
    doi: 10.1016/j.jacc.2008.02.058pubmed: 18510962google scholar: lookup
  84. Álvarez-Cilleros D, López-Oliva E, Goya L, Martín MÁ, Ramos S. Cocoa intake attenuates renal injury in Zucker Diabetic fatty rats by improving glucose homeostasis.. Food Chem Toxicol 2019 May;127:101-109.
    doi: 10.1016/j.fct.2019.03.002pubmed: 30851367google scholar: lookup
  85. Cordero-Herrera I., Martin M.A., Fernández-Millán E., Álvarez C., Goya L., Ramos S.. Cocoa and cocoa flavanol epicatechin improve hepatic lipid metabolism in in vivo and in vitro models. Role of PKCζ. J. Funct. Foods. 2015;17:761–773.
    doi: 10.1016/j.jff.2015.06.033google scholar: lookup
  86. Álvarez-Cilleros D, Ramos S, López-Oliva ME, Escrivá F, Álvarez C, Fernández-Millán E, Martín MÁ. Cocoa diet modulates gut microbiota composition and improves intestinal health in Zucker diabetic rats.. Food Res Int 2020 Jun;132:109058.
    doi: 10.1016/j.foodres.2020.109058pubmed: 32331673google scholar: lookup
  87. Giovinazzo G, Ingrosso I, Paradiso A, De Gara L, Santino A. Resveratrol biosynthesis: plant metabolic engineering for nutritional improvement of food.. Plant Foods Hum Nutr 2012 Sep;67(3):191-9.
    doi: 10.1007/s11130-012-0299-8pubmed: 22777386google scholar: lookup
  88. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.. Science 1997 Jan 10;275(5297):218-20.
    doi: 10.1126/science.275.5297.218pubmed: 8985016google scholar: lookup
  89. Orsu P, Murthy BV, Akula A. Cerebroprotective potential of resveratrol through anti-oxidant and anti-inflammatory mechanisms in rats.. J Neural Transm (Vienna) 2013 Aug;120(8):1217-23.
    doi: 10.1007/s00702-013-0982-4pubmed: 23371441google scholar: lookup
  90. Mokni M, Limam F, Elkahoui S, Amri M, Aouani E. Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia/reperfusion injury.. Arch Biochem Biophys 2007 Jan 1;457(1):1-6.
    doi: 10.1016/j.abb.2006.10.015pubmed: 17125727google scholar: lookup
  91. Bhatt SR, Lokhandwala MF, Banday AA. Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats.. Eur J Pharmacol 2011 Sep 30;667(1-3):258-64.
    doi: 10.1016/j.ejphar.2011.05.026pubmed: 21640096google scholar: lookup
  92. Thandapilly SJ, Wojciechowski P, Behbahani J, Louis XL, Yu L, Juric D, Kopilas MA, Anderson HD, Netticadan T. Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure.. Am J Hypertens 2010 Feb;23(2):192-6.
    doi: 10.1038/ajh.2009.228pubmed: 19942861google scholar: lookup
  93. Bomfim GHS, Musial DC, Méndez-López I, Jurkiewicz A, Jurkiewicz NH, Padín JF, García AG. Chronic resveratrol consumption prevents hypertension development altering electrophysiological currents and Ca(2+) signaling in chromaffin cells from SHR rats.. Cell Signal 2020 Dec;76:109811.
    doi: 10.1016/j.cellsig.2020.109811pubmed: 33075487google scholar: lookup
  94. Sánchez-Lozada LG, Tapia E, Jiménez A, Bautista P, Cristóbal M, Nepomuceno T, Soto V, Avila-Casado C, Nakagawa T, Johnson RJ, Herrera-Acosta J, Franco M. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats.. Am J Physiol Renal Physiol 2007 Jan;292(1):F423-9.
    doi: 10.1152/ajprenal.00124.2006pubmed: 16940562google scholar: lookup
  95. Aguilera AA, Díaz GH, Barcelata ML, Guerrero OA, Ros RM. Effects of fish oil on hypertension, plasma lipids, and tumor necrosis factor-alpha in rats with sucrose-induced metabolic syndrome.. J Nutr Biochem 2004 Jun;15(6):350-7.
    doi: 10.1016/j.jnutbio.2003.12.008pubmed: 15157941google scholar: lookup
  96. Buettner R, Schölmerich J, Bollheimer LC. High-fat diets: modeling the metabolic disorders of human obesity in rodents.. Obesity (Silver Spring) 2007 Apr;15(4):798-808.
    doi: 10.1038/oby.2007.608pubmed: 17426312google scholar: lookup
  97. Ghibaudi L, Cook J, Farley C, van Heek M, Hwa JJ. Fat intake affects adiposity, comorbidity factors, and energy metabolism of sprague-dawley rats.. Obes Res 2002 Sep;10(9):956-63.
    doi: 10.1038/oby.2002.130pubmed: 12226145google scholar: lookup
  98. Ferris HA, Kahn CR. New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it.. J Clin Invest 2012 Nov;122(11):3854-7.
    doi: 10.1172/JCI66180pmc: PMC3484465pubmed: 23093783google scholar: lookup
  99. Wong SK, Chin KY, Suhaimi FH, Ahmad F, Ima-Nirwana S. The Relationship between Metabolic Syndrome and Osteoporosis: A Review.. Nutrients 2016 Jun 7;8(6).
    doi: 10.3390/n聠347pmc: PMC4924188pubmed: 27338453google scholar: lookup
  100. Ranasinghe P, Pigera S, Premakumara GA, Galappaththy P, Constantine GR, Katulanda P. Medicinal properties of 'true' cinnamon (Cinnamomum zeylanicum): a systematic review.. BMC Complement Altern Med 2013 Oct 22;13:275.
    doi: 10.1186/1472-6882-13-275pmc: PMC3854496pubmed: 24148965google scholar: lookup
  101. Jayaprakasha GK, Rao LJ. Chemistry, biogenesis, and biological activities of Cinnamomum zeylanicum.. Crit Rev Food Sci Nutr 2011 Jul;51(6):547-62.
    doi: 10.1080/10408391003699550pubmed: 21929331google scholar: lookup
  102. Medagama AB. The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials.. Nutr J 2015 Oct 16;14:108.
    doi: 10.1186/s12937-015-0098-9pmc: PMC4609100pubmed: 26475130google scholar: lookup
  103. Sheng X, Zhang Y, Gong Z, Huang C, Zang YQ. Improved Insulin Resistance and Lipid Metabolism by Cinnamon Extract through Activation of Peroxisome Proliferator-Activated Receptors.. PPAR Res 2008;2008:581348.
    doi: 10.1155/2008/581348pmc: PMC2602825pubmed: 19096709google scholar: lookup
  104. Couturier K, Batandier C, Awada M, Hininger-Favier I, Canini F, Anderson RA, Leverve X, Roussel AM. Cinnamon improves insulin sensitivity and alters the body composition in an animal model of the metabolic syndrome.. Arch Biochem Biophys 2010 Sep 1;501(1):158-61.
    doi: 10.1016/j.abb.2010.05.032pubmed: 20515642google scholar: lookup
  105. Shalaby MA, Saifan HY. Some pharmacological effects of cinnamon and ginger herbs in obese diabetic rats.. J Intercult Ethnopharmacol 2014 Oct-Dec;3(4):144-9.
    doi: 10.5455/jice.20140818050741pmc: PMC4576807pubmed: 26401364google scholar: lookup
  106. Mollazadeh H, Hosseinzadeh H. Cinnamon effects on metabolic syndrome: a review based on its mechanisms.. Iran J Basic Med Sci 2016 Dec;19(12):1258-1270.
    pmc: PMC5220230pubmed: 28096957doi: 10.22038/ijbms.2016.7906google scholar: lookup
  107. Wojcik M., Krawczyk M., Wozniak L.A.. Antidiabetic activity of curcumin: Insight Into its mechanisms of action. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome. Elsevier; Houston, TX, USA: 2018; pp. 385–401.
  108. Al-Saud NBS. Impact of curcumin treatment on diabetic albino rats.. Saudi J Biol Sci 2020 Feb;27(2):689-694.
    doi: 10.1016/j.sjbs.2019.11.037pmc: PMC6997849pubmed: 32210689google scholar: lookup
  109. Kabirifar R., Ghoreshi Z., Rezaifar A., Binesh F., Bamdad K., Moradi A.. Curcumin, quercetin and atorvastatin protected against the hepatic fibrosis by activating AMP-activated protein kinase. J. Funct. Foods. 2018;40:341–348.
    doi: 10.1016/j.jff.2017.11.020google scholar: lookup
  110. Alongi M., Anese M.. Re-thinking functional food development through a holistic approach. J. Funct. Foods. 2021;81:104466.
    doi: 10.1016/j.jff.2021.104466google scholar: lookup

Citations

This article has been cited 5 times.
  1. Adetunji JA, Fasae KD, Awe AI, Paimo OK, Adegoke AM, Akintunde JK, Sekhoacha MP. The protective roles of citrus flavonoids, naringenin, and naringin on endothelial cell dysfunction in diseases.. Heliyon 2023 Jun;9(6):e17166.
    doi: 10.1016/j.heliyon.2023.e17166pubmed: 37484296google scholar: lookup
  2. Wuyt AK, Nguelefack-Mbuyo EP, Fofié CK, Nguelefack TB. The methanol extract of Ceiba pentandra reverses monosodium glutamate-induced cardiometabolic syndrome in rats via the regulation of dyslipidemia, inflammation, oxidative stress, and insulin sensitization.. Heliyon 2023 Feb;9(2):e13689.
    doi: 10.1016/j.heliyon.2023.e13689pubmed: 36865446google scholar: lookup
  3. Gasmi A, Mujawdiya PK, Noor S, Lysiuk R, Darmohray R, Piscopo S, Lenchyk L, Antonyak H, Dehtiarova K, Shanaida M, Polishchuk A, Shanaida V, Peana M, Bjørklund G. Polyphenols in Metabolic Diseases.. Molecules 2022 Sep 23;27(19).
    doi: 10.3390/molecules27196280pubmed: 36234817google scholar: lookup
  4. Menezes R, Matafome P, Freitas M, García-Conesa MT. Updated Information of the Effects of (Poly)phenols against Type-2 Diabetes Mellitus in Humans: Reinforcing the Recommendations for Future Research.. Nutrients 2022 Aug 30;14(17).
    doi: 10.3390/nᐗ3563pubmed: 36079821google scholar: lookup
  5. Wan M, Li Q, Lei Q, Zhou D, Wang S. Polyphenols and Polysaccharides from Morus alba L. Fruit Attenuate High-Fat Diet-Induced Metabolic Syndrome Modifying the Gut Microbiota and Metabolite Profile.. Foods 2022 Jun 20;11(12).
    doi: 10.3390/foods11121818pubmed: 35742014google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.